Clene Inc.
NASDAQ:CLNNBiotechnology
+$0.08 today
- Market cap
- $52.70M
- Beta
- 0.92
- P/E (TTM)
- -2.1
- EPS (TTM)
- -$2.88
Volume 0.12M
Average 0.50M
CLNN Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Clene Inc.NASDAQ: CLNN
Total Assets · Q1 FY2026 · quarter ended Mar 2026
Total assets falls 14.4% from a year ago
Total assets stood at $21.67M at the end of Q1 FY2026, down 14.4% from a year earlier and up 19.5% from the prior quarter. Over 3 fiscal years it compounded at -25.9% a year.
Context
- Total assets increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total assets keeps falling in the next quarterly balance sheet after a -14.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 18.13M USD
- Year-over-year change
- -33.7%
- 4-year CAGR
- -26.8%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 18.13M | -33.7% |
| FY2024 | 2024-12-31 | 27.34M | -47.8% |
| FY2023 | 2023-12-31 | 52.34M | +17.6% |
| FY2022 | 2022-12-31 | 44.49M | -29.4% |
| FY2021 | 2021-12-31 | 63.06M | — |
Total Assets vs competitors
How CLNN compares with its peers on the latest reported figures
- CLNN's Mar 2026 total assets of $21.67M is the lowest of the 11 companies compared; the peer median is $164.91M.
- Its year-over-year change of -14.4% is the 6th highest of 11, against a peer median of -18.5%.
- Over three fiscal years its annual growth of -25.9% compares with a peer median of -5.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Mar 2026 | $268.85M | +82.2% | +12.6% | |
| Mar 2026 | $253.07M | -34.1% | -19.5% | |
| Mar 2026 | $225.63M | +176.3% | -0.9% | |
| Mar 2026 | $217.87M | -3.0% | -3.9% | |
| Mar 2026 | $202.6M | -41.2% | -13.7% | |
WHWKWhitehawk Therapeutics Inc | Mar 2026 | $127.23M | -45.6% | -6.5% |
| Mar 2026 | $102.12M | +32.3% | -23.7% | |
| Mar 2026 | $58.86M | -36.7% | +21.7% | |
| Dec 2025 | $56.08M | -44.6% | -31.4% | |
| Mar 2026 | $53.27M | +38.7% | +81.2% | |
| Mar 2026 | $21.67M | -14.4% | -25.9% | |
| Peer median (excluding CLNN) | $164.91M | -18.5% | -5.2% | |
Competitors are the stored peer set for CLNN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 50.29M | 18.33M | 28.82M | 12.16M | 5.19M |
| Short-term Investments | 0 | 4.98M | 6.18M | 0 | 0 |
| Net Receivables | 1.61M | 2.97M | 1.34M | 391K | 590K |
| Inventory | 41K | 43K | 37K | 68K | 37K |
| Other Current Assets | 2.45M | 2.87M | 2.48M | 137K | 139K |
| Total Current Assets | 54.58M | 29.2M | 38.85M | 16.16M | 8.98M |
| Property, Plant & Equipment (Net) | 8.42M | 15.24M | 13.43M | 11.12M | 9.1M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 58K | 58K | 0 | 58K | 58K |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 0 | 58K | 0 | 0 |
| Total Non-current Assets | 8.48M | 15.3M | 13.49M | 11.18M | 9.15M |
| Total Assets | 63.06M | 44.49M | 52.34M | 27.34M | 18.13M |
| Account Payables | 1.92M | 3.01M | 1.5M | 1.24M | 892K |
| Short-term Debt | 0 | 6.42M | 19.5M | 359K | 4.07M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 520K | 520K | 0 | 2.67M | 1.51M |
| Other Current Liabilities | 2.05M | 1.49M | 2.12M | 4.08M | 3.14M |
| Total Current Liabilities | 6.03M | 13.86M | 25.33M | 10.29M | 10.78M |
| Long-term Debt | 19.08M | 19.25M | 7.15M | 15.43M | 13.54M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 20.89M | 2.56M | 1.57M | 6.35M | 8.16M |
| Total Non-current Liabilities | 44.44M | 27.4M | 13.62M | 25.9M | 24.95M |
| Total Liabilities | 50.47M | 41.26M | 38.95M | 36.19M | 35.72M |
| Common Stock | 6K | 7K | 13K | 1K | 1K |
| Retained Earnings | (163.3M) | (193.22M) | (242.72M) | (282.12M) | (308.3M) |
| Accumulated OCI | 233K | 203K | 199K | 71K | 172K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 12.6M | 3.24M | 13.39M | (8.86M) | (17.59M) |
| Total Debt | 24.04M | 31.82M | 32.16M | 20.84M | 21.67M |
| Net Debt | (26.25M) | 13.49M | 3.34M | 8.69M | 16.48M |
Clene Inc.
NASDAQ:CLNN
Intrinsic Alpha fair value
Locked
Current Price
$3.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.